Budesonide and Atazanavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Atazanavir (atazanavir). Common drug interactions include cushing's syndrome among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Atazanavir. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Atazanavir?

Atazanavir has active ingredients of atazanavir. eHealthMe is studying from 2,296 Atazanavir users. Check the latest studies of Atazanavir.



On Jul, 24, 2026

26 people who take Budesonide and Atazanavir together, and have interactions are studied.

Budesonide and Atazanavir drug interactions.

What are the common drug interactions of Budesonide and Atazanavir, by gender? *:

female:

  1. Cushing's syndrome (obesity, a rounded face, increased fat)
  2. Asthenia (weakness)
  3. Cushingoid (obesity and weakening of the muscles)
  4. Muscular weakness (muscle weakness)
  5. Skin fragility (trauma-induced blisters and erosions of skin)
  6. Skin striae (irregular areas of skin that look like bands, stripes, or lines)
  7. Insomnia (sleeplessness)
  8. Weight increased

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Chronic kidney disease
  5. Clavicle fracture
  6. Cushing's syndrome (obesity, a rounded face, increased fat)
  7. Emotional distress
  8. Osteoporosis (bones weak and more likely to break)
  9. Pain
  10. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)

What are the common drug interactions of Budesonide and Atazanavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cushing's syndrome (obesity, a rounded face, increased fat)
  2. Clavicle fracture
  3. Emotional distress
  4. Osteoporosis (bones weak and more likely to break)
  5. Pain
  6. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  7. Blood creatinine decreased
  8. Bone density decreased
  9. Insomnia (sleeplessness)
  10. Weight increased

50-59:

n/a

60+:

  1. Cushing's syndrome (obesity, a rounded face, increased fat)

What are the existing conditions these people have? *

  1. Hiv Infection: 24 people, 92.31%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 19.23%
  3. Hepatitis C: 2 people, 7.69%
  4. Allergic Rhinitis: 2 people, 7.69%
  5. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Atazanavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Budesonide and Atazanavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Atazanavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atazanavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and atazanavir (the active ingredients of Budesonide and Atazanavir, respectively), and Budesonide and Atazanavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: